Northern Health is taking significant strides to enhance access to cancer clinical trials for some of the most vulnerable members of the community, particularly those from culturally and linguistically diverse (CALD) backgrounds.
Many CALD patients encounter obstacles such as language barriers and cultural differences, which may restrict their participation in these important trials.
With the support of a North Eastern Melbourne Integrated Cancer Services (NEMICS) service improvement grant, alongside a TrialHub grant, Northern Health is launching an initiative aimed at building capacity and expanding local access to clinical trials specifically for CALD communities within its catchment.
This project is informed by valuable feedback from consumers, clinical staff, and transcultural and language services (TALS) staff, and will focus on developing new tools and support systems to facilitate better engagement for CALD patients in cancer clinical trials.
The cancer clinical trials team at Northern Health unites specialists from haematology, oncology, pharmacy, research, interpreting and members of the CALD community.
Scientist Sharni Norouzi said the goal is to ensure that every patient, regardless of background, has equal access to the opportunities and benefits that clinical trials offer for cancer treatment.
For patients, it will enhance access to cancer clinical trials, ensuring that CALD communities receive the same opportunities and care as others.
For healthcare staff, the project will deliver new tools, resources, and training, enhancing their ability to engage effectively with CALD patients regarding clinical trials.
Greek Interpreter Kostas Karamarkos, said participating in the project meant that language support goes beyond mere translation and interpretation.
“It ensures that patients feel heard, respected, and actively involved in their care decisions,” he said.
